Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1
M Mesnil, H Yamasaki - Cancer research, 2000 - AACR
Antitumor suicide gene therapy is one of the emerging strategies against cancer. It consists
of the introduction into cancer cells of a gene capable of converting a nontoxic prodrug into a …
of the introduction into cancer cells of a gene capable of converting a nontoxic prodrug into a …
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
GM Dubowchik, MA Walker - Pharmacology & therapeutics, 1999 - Elsevier
This review is a survey of various approaches to targeting cytotoxic anticancer drugs to
tumors primarily through biomolecules expressed by cancer cells or associated vasculature …
tumors primarily through biomolecules expressed by cancer cells or associated vasculature …
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
LA Wheeler, AG Manzanera, SD Bell… - Neuro …, 2016 - academic.oup.com
Background Despite aggressive standard of care (SOC) treatment, survival of malignant
gliomas remains very poor. This Phase II, prospective, matched controlled, multicenter trial …
gliomas remains very poor. This Phase II, prospective, matched controlled, multicenter trial …
Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives
O Greco, GU Dachs - Journal of cellular physiology, 2001 - Wiley Online Library
Gene therapy of cancer is a novel approach with the potential to selectively eradicate tumour
cells, whilst sparing normal tissue from damage. In particular, gene‐directed enzyme …
cells, whilst sparing normal tissue from damage. In particular, gene‐directed enzyme …
Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene …
The long-term consequences of adenovirus-mediated conditional cytotoxic gene therapy for
gliomas remain uncharacterized. We report here detection of active brain inflammation 3 …
gliomas remain uncharacterized. We report here detection of active brain inflammation 3 …
In Vivo Cancer Gene Therapy by Adenovirus-mediated Transfer of a Bifunctional Yeast Cytosine Deaminase/Uracil Phosphoribosyltransferase Fusion Gene
P Erbs, E Regulier, J Kintz, P Leroy, Y Poitevin… - Cancer research, 2000 - AACR
Direct transfer of prodrug activation systems into tumors was demonstrated to be an
attractive method for the selective in vivo elimination of tumor cells. However, most current …
attractive method for the selective in vivo elimination of tumor cells. However, most current …
Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery
G Almeida-Porada, AJ Atala, CD Porada - Molecular Therapy-Methods & …, 2020 - cell.com
Mesenchymal stromal cells (MSCs) possess several fairly unique properties that, when
combined, make them ideally suited for cellular-based immunotherapy and as vehicles for …
combined, make them ideally suited for cellular-based immunotherapy and as vehicles for …
A phase I/II study of herpes simplex virus type 1 thymidine kinase “suicide” gene therapy for recurrent glioblastoma
D Klatzmann, CA Valery, G Bensimon, B Marro… - Human gene …, 1998 - liebertpub.com
Despite extensive surgery for glioblastoma, residual tumor cells always lead to relapse.
Gene therapy based on retrovirus-mediated gene transfer of herpes simplex virus type 1 …
Gene therapy based on retrovirus-mediated gene transfer of herpes simplex virus type 1 …
Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor
L Yang, N Yamagata, R Yadav… - The Journal of …, 2003 - Am Soc Clin Investig
Prostaglandin E2 (PGE2), a major COX metabolite, plays important roles in several facets of
tumor biology. We characterized the contribution of the PGE2 EP2 receptor to cancer …
tumor biology. We characterized the contribution of the PGE2 EP2 receptor to cancer …
Current and future strategies for the treatment of malignant brain tumors
MG Castro, R Cowen, IK Williamson, A David… - Pharmacology & …, 2003 - Elsevier
Glioblastoma (GB) is the most common subtype of primary brain tumor in adults. These
tumors are highly invasive, very aggressive, and often infiltrate critical neurological areas …
tumors are highly invasive, very aggressive, and often infiltrate critical neurological areas …